Cart
sales@molnova.com
Thioguanine
CAS No. 154-42-7
Thioguanine ( —— )
Catalog No. M18075 CAS No. 154-42-7
Thioguanine is an antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 36 | In Stock |
|
| 100MG | 43 | In Stock |
|
| 500MG | 65 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThioguanine
-
NoteResearch use only, not for human use.
-
Brief DescriptionThioguanine is an antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.
-
DescriptionTioguanine (INN, BAN), or thioguanine (AAN, USAN), commonly referred to as 6-thioguanine (6-TG) is a medication used to treat a number of types of leukemia. It has been used less frequently in recent years because of safety concerns. However, it is becoming more widely used for treating ulcerative colitis and some autoimmune diseases.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDNMT1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number154-42-7
-
Formula Weight167.2
-
Molecular FormulaC5H5N5S
-
Purity98%
-
SolubilityDMSO : 10 mg/mL 59.81 mM;
-
SMILESc1nc2c([nH]1)c(=S)nc([nH]2)N
-
Chemical Name2-amino-1H-purine-6(7H)-thione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Krynetskaia NF, et al. FASEB J,2000, 14(14), 2339-2344.
molnova catalog
related products
-
6,7,4'-Trihydroxyfla...
6,7,4'-Trihydroxyflavanone possesses various pharmacological activities, including anti-rheumatic, anti-ischemic, anti-inflammatory, anti-osteoclastogenic, and protective effects against METH-induced deactivation of T cells. 6,7,4'-Trihydroxyflavanone can be used for studies about the treatment of METH-addicts suffering from neurodegenerative diseases.
-
Kemptide
Kemptide is a synthetic heptapeptide, acting as a substrate for cAMP-dependent protein kinase (PK).
-
ACT-389949
ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.
